GREENVILLE, N.C. — Nipro Medical Corporation, as part of Nipro Corporation Japan, a leader in the global healthcare and medical device industry, proudly announces its significant expansion in the United States with the establishment of its first North American manufacturing facility in Greenville, North Carolina. This is a strategic development in the further growth of Nipro.
Governor Roy Cooper Welcomes Nipro to North Carolina
Governor Roy Cooper expressed his enthusiasm about Nipro’s decision to expand to North Carolina, highlighting the state's reputation as a center for advanced manufacturing. “We are delighted to welcome Nipro to North Carolina," Governor Cooper stated. "This initiative not only reinforces our status as a prime location for advanced manufacturing but also demonstrates our state's capability in providing a skilled workforce and a superior quality of life.”
Nipro to Enhance Local Production and Job Creation
Founded in Japan, Nipro stands as a Tier 1 manufacturer renowned for its high-quality medical devices and healthcare solutions. Tsuyoshi Yamazaki, Senior Managing Director of Global Business at Nipro, shared his excitement about the new facility. “We are thrilled to start manufacturing our cutting-edge medical devices in the U.S., which will support local healthcare professionals and patients with a stable supply chain and reduced transportation costs," said Yamazaki. “Our close proximity to customers will allow us to better respond to their needs and provide them with timely and effective solutions.”
This investment highlights Nipro’s commitment to innovation, growth, and environmental sustainability.
By establishing manufacturing in the United States, Nipro will significantly reduce global transportation needs, cutting down on carbon emissions. This initiative underscores Nipro’s dedication to minimizing environmental impact and fostering a sustainable future.
"Our new facility in Greenville is a major milestone in our sustainability journey, reflecting our commitment to reducing our carbon footprint," said Mr. Yamazaki.
Nipro continues to lead by example in the medical device industry, championing environmental stewardship and sustainable practices.
A Testament to International Commitment
Akira Shimizu, CEO of Nipro Medical Corporation, reflected on the significant impact of this expansion. “This new facility marks a major milestone in Nipro's commitment to the U.S. market, allowing us to deliver high-quality medical devices that enhance patient outcomes and quality of life across the country,” said Shimizu.
Significant Economic Impact and Job Opportunities
The new facility in Pitt County marks Nipro's first venture into producing advanced medical devices directly in the U.S. market. The advanced manufacturing site will host a range of positions from engineering and production to administrative and management roles. Nipro values ownership, flexibility, and team spirit among its employees. People who are willing to make a difference and contribute to Nipro’s mission are welcome to join and grow with the company.
North Carolina: A Hub for STEM and Manufacturing Talent
N.C. Commerce Secretary Machelle Baker Sanders noted, “North Carolina’s rich environment for STEM talent and our robust manufacturing workforce make it an ideal location for global healthcare leaders like Nipro. Our commitment to fostering growth ensures that North Carolina remains at the forefront of medical innovation and manufacturing.”
Supporting Patients with Diabetes and Chronic Kidney Disease
The North Carolina facility is set to produce state-of-the-art medical devices that support patients with diabetes, chronic kidney disease, and other renal health issues, reflecting Nipro's commitment to enhancing the quality of patient care through innovative medical technologies.
Vice President of Manufacturing Operations and Inaugural Site Leader for the Greenville Medical Device Plant Anticipates Collaboration and Success
Krizay Elenitoba-Johnson, Vice President of Manufacturing Operations and Inaugural Site Leader for the Greenville Medical Device Plant, expressed anticipation for the collaborative opportunities ahead. “I look forward to working with our dedicated team and the supportive community here to achieve great successes,” Elenitoba-Johnson remarked.
For further information, please contact:
Krizay Elenitoba-Johnson
Vice President of Manufacturing Operations and Inaugural Site Leader for the
Greenville Medical Device Plant.
Frequently Asked Questions (FAQs)
within the U.S. market directly. Nipro's initiative in North Carolina is focused on delivering top-tier dialysis care as well as supplying pharmaceutical needles to pharmaceutical companies.
The event was a unique fusion of traditional Japanese rituals and modern aspirations. A Japanese priestess performed the "Ji Chin Sai" ceremony, a time-honored practice to bless the land and pray for the safety and success of the construction, symbolizing Nipro's respect for cultural traditions while forging a new path in the U.S.
The cherry blossom, emblematic of renewal and optimism, coupled with the dogwood flower (official state flower of North Carolina), emblematic of resilience and fortitude, represent Nipro's aspirations for growth and strength in the U.S. These blossoms are a nod to the company's Japanese heritage and its commitment to thriving within the local community.
The primary mission of the North Carolina facility is to cater to the North American market's needs. However, given Nipro's extensive global network, the possibility of exporting to other regions, such as Latin America , remains open for future consideration.
Nipro's local manufacturing of dialyzers and precision needles is expected to bolster the local economy through job creation and contribute to environmental sustainability by minimizing the carbon footprint associated with long-distance transport of medical supplies.
The new facility is set to produce state-of-the-art medical devices that support patients with diabetes, chronic kidney disease, and other renal health issues, reflecting Nipro's commitment to enhancing the quality of patient care through innovative medical technologies.
Nipro's dedication to the healthcare industry is evident in its commitment to meeting the immediate healthcare needs of the American people. The company's focus on local production underscores its role as a key player in the global healthcare landscape.
Nipro, established in 1954, has a rich history as a Japanese enterprise specializing in medical equipment manufacturing. The company's ethos is centered around delivering exceptional healthcare globally, with a forward-looking vision to foster a healthier future for all. It stems from its founder’s entrepreneurial spirit and that spirit continues as it still pushes the current colleagues to go beyond. “Willingness” has been the corporate creed, and remains a very important corporate value.
Nipro values ownership, flexibility, and team spirit among its employees. Willingness was the one thing that pushed its founder and that spirit has carried forward. People who are willing to make a difference and to contribute to our mission, are welcome to join us and grow with us.
The culture is built upon our guiding principle of “Sanpo Yoshi”, this means triple win – or we do good for all. Every colleague needs to feel how they contribute to this triple win. We always put our end-users viewpoints first and will at all times welcome any initiatives to improve. The “infinity” symbol in our logo represents the Deming Circle, hinting to continuous improvement. Mistakes can happen, as long as we learn from them and are eager to fix things for our patients.
Nipro will begin recruiting in Q1 2026. If you are interested in applying ahead of this period, we encourage you to share your interest with us. We will be creating a dedicated page on our website for this purpose.
The first products from our new facility are expected to be released following the completion of foundation and construction, which will begin in Q4 2024.
We will provide more specific timelines as the project progresses.
The first products from our new facility are scheduled to be released in Q3 2027.
We appreciate your interest and will keep you updated as we approach this milestone.
Nipro has a significant presence in the U.S. through Nipro PharmaPackaging Americas, with establishments in Westport – Indiana, Chase City – West Virginia and Millville – New Jersey. The company is closely located to its main customers, providing pharmaceutical glass tubing for primary packaging.
Also in New Jersey (in Bridgewater), we have a sales office that runs the commercial side of our business. We also have an establishment in Pennsylvania, called Nipro Solutions. And, in Arizona, we still have one more company that covers the machine part of dialysis treatments. Finally, our regional headquarters are situated in Miami, FL.